Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new path to platelet production through matrix sensing.
Abbonante V, Di Buduo CA, Gruppi C, De Maria C, Spedden E, De Acutis A, Staii C, Raspanti M, Vozzi G, Kaplan DL, Moccia F, Ravid K, Balduini A. Abbonante V, et al. Haematologica. 2017 Jul;102(7):1150-1160. doi: 10.3324/haematol.2016.161562. Epub 2017 Apr 14. Haematologica. 2017. PMID: 28411253 Free PMC article.
Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application.
Achilli C, Grandi S, Ciana A, Guidetti GF, Malara A, Abbonante V, Cansolino L, Tomasi C, Balduini A, Fagnoni M, Merli D, Mustarelli P, Canobbio I, Balduini C, Minetti G. Achilli C, et al. Among authors: abbonante v. Nanomedicine. 2014 Apr;10(3):589-97. doi: 10.1016/j.nano.2013.10.003. Epub 2013 Oct 23. Nanomedicine. 2014. PMID: 24161383
Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets.
Achilli C, Jadhav SA, Guidetti GF, Ciana A, Abbonante V, Malara A, Fagnoni M, Torti M, Balduini A, Balduini C, Minetti G. Achilli C, et al. Among authors: abbonante v. Chem Biol Drug Des. 2014 May;83(5):532-40. doi: 10.1111/cbdd.12264. Epub 2014 Mar 18. Chem Biol Drug Des. 2014. PMID: 24666508
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
Pietra D, Rumi E, Ferretti VV, Di Buduo CA, Milanesi C, Cavalloni C, Sant'Antonio E, Abbonante V, Moccia F, Casetti IC, Bellini M, Renna MC, Roncoroni E, Fugazza E, Astori C, Boveri E, Rosti V, Barosi G, Balduini A, Cazzola M. Pietra D, et al. Among authors: abbonante v. Leukemia. 2016 Feb;30(2):431-8. doi: 10.1038/leu.2015.277. Epub 2015 Oct 9. Leukemia. 2016. PMID: 26449662 Free PMC article.
35 results